I have mine ready
Flynn McGuire at the University of Utah, for example, said: The amount of hype to evidence is so skewed, its crazy, and that BPC-157 Should not be used by humans. At the same time, other physicians and researchers see things differently, and are prescribing BPC-157 for a wide variety of illnesses and injuries: ulcerative colitis, orthopedic injuries, and even mental health
The peptide's effectiveness when given either continuously (daily) or intermittently (4 applications over 10 days) suggests sustained biological effects beyond the peptide's short plasma half-life
This line of research directly informed the development of Dihexa
In non-US marketing experience, a dose of 70 mg/kg has been used to treat pediatric patients
Clinical data shows that most participants in tirzepatide trials regained significant weight within one year of stopping treatment